BR9912004A - Oxazolidinonas para tratar infecções dos olhos - Google Patents

Oxazolidinonas para tratar infecções dos olhos

Info

Publication number
BR9912004A
BR9912004A BR9912004-6A BR9912004A BR9912004A BR 9912004 A BR9912004 A BR 9912004A BR 9912004 A BR9912004 A BR 9912004A BR 9912004 A BR9912004 A BR 9912004A
Authority
BR
Brazil
Prior art keywords
oxazolidinones
eye infections
treat eye
treat
oxazolidinone
Prior art date
Application number
BR9912004-6A
Other languages
English (en)
Inventor
Robert Cochran
Charles W Ford
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BR9912004A publication Critical patent/BR9912004A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

<B>OXAZOLIDINONAS PARA TRATAR INFECçõES DOS OLHOS<D> A presente invenção envolve um método de tratar uma infecção oftálmica em um mamífero de sangue quente útil que necessita de tal tratamento que compreende administração tópica de uma quantidade oftalmologicamente eficaz de uma OXAZOLIDINONA.
BR9912004-6A 1998-07-14 1999-07-07 Oxazolidinonas para tratar infecções dos olhos BR9912004A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9276598P 1998-07-14 1998-07-14
PCT/US1999/012367 WO2000003710A1 (en) 1998-07-14 1999-07-07 Oxazolidinones to treat eye infections

Publications (1)

Publication Number Publication Date
BR9912004A true BR9912004A (pt) 2001-04-10

Family

ID=22235050

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9912004-6A BR9912004A (pt) 1998-07-14 1999-07-07 Oxazolidinonas para tratar infecções dos olhos

Country Status (27)

Country Link
US (2) US6337329B1 (pt)
EP (1) EP1096934B1 (pt)
JP (1) JP2002520359A (pt)
KR (1) KR20010079530A (pt)
CN (1) CN1305374A (pt)
AT (1) ATE304886T1 (pt)
AU (1) AU740781B2 (pt)
BG (1) BG64666B1 (pt)
BR (1) BR9912004A (pt)
CA (1) CA2334811A1 (pt)
DE (1) DE69927380T2 (pt)
DK (1) DK1096934T3 (pt)
EA (1) EA003274B1 (pt)
EE (1) EE200100026A (pt)
ES (1) ES2249020T3 (pt)
HU (1) HUP0102836A3 (pt)
ID (1) ID27276A (pt)
IL (1) IL140769A0 (pt)
NO (1) NO20010202D0 (pt)
NZ (1) NZ509375A (pt)
PL (1) PL345544A1 (pt)
PT (1) PT1096934E (pt)
SG (1) SG125079A1 (pt)
SK (1) SK20332000A3 (pt)
TR (1) TR200100066T2 (pt)
WO (1) WO2000003710A1 (pt)
ZA (1) ZA200100038B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR020660A1 (es) * 1998-09-30 2002-05-22 Alcon Lab Inc Composiciones antibioticas para el tratamiento de ojos, oidos y nariz
ATE337002T1 (de) * 1999-09-13 2006-09-15 Insite Vision Inc Topische behandlung zur vorbeugung von augeninfektionen
US6562820B2 (en) 2000-07-05 2003-05-13 Pharmacia & Upjohn Company Method for treatment and prevention of mastitis
PE20020300A1 (es) * 2000-08-22 2002-05-10 Pharmacia Corp Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
AR031135A1 (es) * 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
US7125568B2 (en) 2001-08-23 2006-10-24 Sung Michael T Lipophilic drug compositions
US20030069235A1 (en) * 2001-09-14 2003-04-10 J. Greg Slatter Treatment for ocular infections
JP2005521691A (ja) * 2002-02-22 2005-07-21 ファルマシア・コーポレーション シクロデキストリン化合物及び塩化セチルピリジニウムを含有する眼科用抗菌性薬物製剤
TW201043267A (en) * 2009-03-19 2010-12-16 Intervet Int Bv In situ constituting a vaccine for administration to a predetermined herd of animals
CN101766628B (zh) * 2010-01-20 2012-07-04 广东宏盈科技有限公司 一种眼科外用抗细菌感染药物
EP2895161B1 (en) * 2012-09-13 2017-05-03 Starpharma Pty Limited Method of treatment or prophylaxis of infections of the eye

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
US5231188A (en) * 1989-11-17 1993-07-27 The Upjohn Company Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents
AU667198B2 (en) * 1991-11-01 1996-03-14 Pharmacia & Upjohn Company Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
JP3698724B2 (ja) 1993-11-22 2005-09-21 ファルマシア・アンド・アップジョン・カンパニー 置換−ヒドロキシアセチルピペラジンフェニルオキサゾリジノンのエステル
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
DE4425612A1 (de) 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
WO1997045137A1 (en) * 1996-05-31 1997-12-04 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis

Also Published As

Publication number Publication date
TR200100066T2 (tr) 2001-05-21
CA2334811A1 (en) 2000-01-27
JP2002520359A (ja) 2002-07-09
DE69927380D1 (de) 2005-10-27
KR20010079530A (ko) 2001-08-22
WO2000003710A1 (en) 2000-01-27
US20020065280A1 (en) 2002-05-30
DK1096934T3 (da) 2005-11-28
HUP0102836A3 (en) 2003-12-29
ATE304886T1 (de) 2005-10-15
NO20010202L (no) 2001-01-12
ES2249020T3 (es) 2006-03-16
HUP0102836A2 (hu) 2002-05-29
EP1096934A1 (en) 2001-05-09
AU740781B2 (en) 2001-11-15
PT1096934E (pt) 2005-11-30
US6740652B2 (en) 2004-05-25
CN1305374A (zh) 2001-07-25
IL140769A0 (en) 2002-02-10
NZ509375A (en) 2003-11-28
SK20332000A3 (sk) 2001-05-10
BG64666B1 (bg) 2005-11-30
ZA200100038B (en) 2002-01-02
ID27276A (id) 2001-03-22
DE69927380T2 (de) 2006-07-06
AU4953099A (en) 2000-02-07
EP1096934B1 (en) 2005-09-21
SG125079A1 (en) 2006-09-29
BG105142A (en) 2001-10-31
NO20010202D0 (no) 2001-01-12
EA003274B1 (ru) 2003-04-24
EE200100026A (et) 2002-06-17
US6337329B1 (en) 2002-01-08
EA200100133A1 (ru) 2001-06-25
PL345544A1 (en) 2001-12-17

Similar Documents

Publication Publication Date Title
BR9912004A (pt) Oxazolidinonas para tratar infecções dos olhos
BR0115653A (pt) Composição pronta para o uso para a descoloração ou a deformação para fibras queratìnicas, composição anidra para a descoloração ou a deformação das fibras queratìnicas, composição para a deformação permanente, processo de descoloração ou de deformação permanente das fibras queratìnicas e dispositivo com dois compartimentos ou &#39;kit&#39; para a descoloração ou a deformação permanente das fibras queratìnicas humanas
BR9710768A (pt) Composto composi-Æo e processos para tratamento de infec-{es bacterianas em um mamifero hospedeiro com necessidade de tal tratamento e para prepara-Æo de 6-0-metileritromicina forma i
PT867178E (pt) Utilizacao de agonistas nao alostericos de gaba para o tratamento de desordens do sono
MX9204381A (es) Metodo para tratar inflamacion ocular
DE59802356D1 (de) Lagerstabile ophthalmische zusammensetzungen, umfassend diclofenac und ofloxacin
PA8486001A1 (es) Composiciones de celecoxib
CO5050303A1 (es) Composicion farmaceutica para tratar infecciones virales y metodos para su preparacion su aplicacion
DK0880350T3 (da) Behandling af dissemineret sklerose
BR0206639A (pt) Combinações de inibidor(es) da absorção do esterol com modificador(es) do sangue para o tratamento de condições vasculares
NO307687B1 (no) Anvendelse av riluzol ved fremstilling av medikamenter for behandling av neuro-AIDS
DK0699439T3 (da) Behandling af sygdomme forårsaget af talgkirtellidelser med acyl-CoA-cholesterolacyltransferaseinhibitorer
PT752813E (pt) Inibidores de proteases de parasitas metazoarios
BR9805318A (pt) Método para tratamento de infecções dos olhos com azitromicina.
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
ATE383852T1 (de) Kupferchelatbildner zur behandlung von augenentzündungen
BR0215144A (pt) Composição para tratar lentes de contato
ES2069823T3 (es) Tratamiento de la hipertension ocular con una combinacion sinergica ocular.
DE60030300D1 (de) Topische behandlung zur vorbeugung von augeninfektionen
EA200100010A1 (ru) Местное применение оксазолидинонов для трансдермальной доставки
DE69635282D1 (de) Behandlung der exzessiven aggressivität mit olanzapine
ECSP992967A (es) Aplicación topica de oxazolidinonas para administracion transdermica
MX9700626A (es) USO DE AZASPIRANOS EN LA REPARACIaN DE COMPOSICIONES PARA TRATAR INFECCIONES OPORTUNISTAS.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI